Austin Utilities recognized as a reliable public power provider
Apr. 14—Austin Utilities has earned a Reliable Public Power Provider (RP3) designation from the American Public Power Association for providing reliable and safe electric service.
The RP3 designation, which lasts for three years, recognizes public power utilities that demonstrate proficiency in four key disciplines: reliability, safety, workforce development, and system improvement.
"Receiving an RP3 designation is a great honor signifying a utility has demonstrated commitment to industry best practices," said Jeremy Ash, Chair of APPA's RP3 Review Panel and General Manager at Kansas City Board of Public Utilities, Kansas. "And ultimately, the culture developed from this pursuit of excellence and continued improvement through the RP3 program results in measurable value delivered to the local community."
Criteria include sound business practices and a utility-wide commitment to safe and reliable delivery of electricity. Austin Utilities joins more than 250 public power utilities nationwide that hold the RP3 designation.
"We couldn't be prouder to be honored with this designation," said Mark Nibaur, General Manager of Austin Utilities. "This is the culmination of a lot of work from a lot of people who really care about powering our community. But this designation is not a final destination. We are committed to continuing to look for ways to improve our operations and service to our customers."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Valmet unveils new financial reporting structure and operating model
Finnish company Valmet has revised its financial reporting structure to better reflect its new strategy and operating model. The new operating model and reporting structure will be effective from 1 July 2025. The revised structure will see Valmet reporting under two main segments, Biomaterial Solutions and Services and Process Performance Solutions. The biomaterial segment will offer technology solutions and services for the life cycle of customers in the pulp, paper, and energy industries. It is divided into three business areas: Pulp, Energy and Circularity; Packaging and Paper; and Tissue. These business areas will focus on integrating technology deliveries with life cycle services to enhance customer proximity and value creation. Process Performance Solutions, meanwhile, will provide flow control technologies and automation solutions, serving a wide range of customer industries globally. This segment includes the Flow Control business area and the Automation Solutions business area. For each business area, Valmet will disclose orders received, net sales, and personnel numbers. The company will also continue to provide financial data for five geographical areas: North America, Central America, EMEA, China, and Asia-Pacific. The new reporting structure aligns with Valmet management's approach to monitoring operational performance. Financial information will be restated to reflect the new structure in the January-September 2025 Interim Review, with unaudited data for 2024 and the first quarter of 2025 provided for comparison. In the first quarter of 2025, both segments received total orders worth €1.3bn ($1.5bn) and recorded net sales of €1.18bn. Valmet has also outlined its 2030 financial targets, aiming for a 5% organic net sales growth over the cycle, a comparable earnings before interest, taxes, and amortisation margin (EBITDA) of 15%, a comparable return on capital employed before taxes of 20%, and maintaining gearing below 50%. The company has set strategic missions for each segment. The Biomaterial Solutions and Services segment aims to advance circularity, with a focus on life cycle services, innovation towards circularity, and product cost competitiveness. It targets doubling organic growth in biomaterial services to 8% and reaching a 14% comparable EBITA margin by 2030. The Process Performance Solutions segment's mission is to unlock resource efficiency, with priorities such as leading life cycle value, customer-focused innovation, and growth in high-quality technologies. By 2030, this segment aims to accelerate organic growth to over double the market rate and achieve a 20% comparable EBITA margin. Valmet reiterates its 2025 guidance, estimating that net sales and comparable EBITA will remain at the previous year's levels of €5.35bn and €609m, respectively. Earlier this week, Valmet secured a furnace upgrade and a long-term service agreement from Eren Holding for Shotton Mill in the UK. "Valmet unveils new financial reporting structure and operating model" was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
3 days ago
- Yahoo
Valmet changes its financial reporting structure aligned with new strategy and provides comparative segment information for 2024 and January-March 2025
Valmet Oyj's stock exchange release on June 4, 2025 at 8:30 p.m. EEST ESPOO, Finland, June 4, 2025 /PRNewswire/ -- Valmet changes its financial reporting structure to reflect its new strategy, which was published today, and the new operating model announced on March 31, 2025. The new operating model and reporting structure will take effect on July 1, 2025. In the new financial reporting structure, Valmet consists of two reportable segments: Biomaterial Solutions and Services, and Process Performance Solutions. Biomaterial Solutions and Services segment provides technology solutions and services throughout the lifecycle for its customers who operate mainly in pulp, paper and energy industries. Process Performance Solutions segment delivers flow control technologies as well as automation solutions ranging from single measurements to mill- or plant-wide process automation systems, along with the associated services. It has a diversified portfolio of customer industries globally. The two segments are comprised of business areas as follows: Biomaterial Solutions and Services segment consists of three business areas:- Pulp, Energy and Circularity- Packaging and Paper- Tissue Process Performance Solutions segment consists of two business areas:- Flow Control- Automation Solutions The business areas Pulp, Energy and Circularity; Packaging and Paper; and Tissue combine Valmet's technology and service businesses for their respective customer industries. Each business area integrates technology deliveries and lifecycle services to strengthen customer proximity, lifecycle focus, and value creation with industry-specific offerings. The Flow Control business area corresponds to the former Flow Control business line. The Automation Solutions business area was previously called Automation Systems business line. For both reportable segments, Valmet will report orders received, net sales and profitability (EBITA and comparable EBITA), as well as amortization and items affecting comparability. Valmet will also report services orders received and net sales for the Biomaterial Solutions and Services segment to maintain visibility to this strategically important part of the business. For each business area, Valmet will report orders received, net sales and personnel. Valmet will continue to report orders received, net sales and personnel for the five geographical areas: North America, Latin America (previously South America), EMEA, China and Asia-Pacific. The new reporting structure is aligned with the way Valmet management follows the operational performance of Valmet's businesses. Valmet will change its financial reporting structure to correspond to the new operating model in its January–September 2025 Interim Review. To provide a basis for comparison, the following tables show financial information with the new reporting structure on an unaudited basis for all four quarters and full year 2024, as well as first quarter of 2025. As additional information Valmet plans to publish the corresponding financial information for the first six months of 2025 and for the second quarter 2025 in its Half Year Financial Review 2025. Quarterly information Orders received, EUR million Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services 722 930 719 2 020 4 392 926 Pulp, Energy and Circularity 259 367 321 1 336 2 283 465 Packaging and Paper 298 402 317 412 1 428 340 Tissue 166 162 81 272 681 121 Of which service 527 497 412 479 1 915 568 Process Performance Solutions 328 352 322 443 1 446 406 Flow Control 194 195 188 185 763 215 Automation Solutions 134 157 133 258 683 191 Total 1 050 1 283 1 041 2 463 5 837 1 332 Net sales, EUR million Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services 903 973 941 1 104 3 922 846 Pulp, Energy and Circularity 367 386 380 442 1 574 339 Packaging and Paper 412 443 417 474 1 746 387 Tissue 124 144 145 189 602 119 Of which service 406 473 453 567 1 900 433 Process Performance Solutions 309 351 354 424 1 437 339 Flow Control 188 201 196 206 791 192 Automation Solutions 121 150 158 217 646 147 Total 1 212 1 324 1 295 1 528 5 359 1 184 Comparable EBITA, EUR million Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services 80 95 101 128 403 82 Process Performance Solutions 51 58 65 81 255 55 Other -11 -12 -10 -17 -49 -16 Total 121 141 156 192 609 121 Comparable EBITA, % of net sales Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services 8.9 % 9.8 % 10.7 % 11.6 % 10.3 % 9.7 % Process Performance Solutions 16.5 % 16.5 % 18.3 % 19.1 % 17.7 % 16.2 % Total 10.0 % 10.6 % 12.0 % 12.6 % 11.4 % 10.2 % EBITA, EUR million Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services 77 87 84 116 364 80 Process Performance Solutions 50 58 64 76 248 54 Other -14 -13 -10 -19 -56 -21 Total 114 132 138 173 557 113 EBITA, % of net sales Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services 8.6 % 9.0 % 8.9 % 10.5 % 9.3 % 9.5 % Process Performance Solutions 16.2 % 16.4 % 18.2 % 17.9 % 17.2 % 16.0 % Total 9.4 % 9.9 % 10.7 % 11.3 % 10.4 % 9.6 % Items affecting comparability, EUR million Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services -3 -8 -17 -12 -39 -2 Process Performance Solutions -1 0 0 -5 -7 -1 Other -3 -1 0 -3 -7 -5 Total -7 -9 -17 -19 -53 -8 Amortization, EUR million Q1/2024 Q2/2024 Q3/2024 Q4/2024 2024 Q1/2025 Biomaterial Solutions and Services -11 -11 -11 -5 -36 -6 Process Performance Solutions -12 -14 -14 -14 -54 -14 Other -4 -4 -4 -5 -18 -5 Total -27 -29 -29 -23 -108 -24 Year-to-date information Orders received, EUR million Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services 722 1 653 2 372 4 392 926 Pulp, Energy and Circularity 259 625 946 2 283 465 Packaging and Paper 298 700 1 016 1 428 340 Tissue 166 328 409 681 121 Of which service 527 1 024 1 436 1 915 568 Process Performance Solutions 328 681 1 002 1 446 406 Flow Control 194 389 578 763 215 Automation Solutions 134 291 425 683 191 Total 1 050 2 333 3 374 5 837 1 332 Net sales, EUR million Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services 903 1 877 2 818 3 922 846 Pulp, Energy and Circularity 367 753 1 132 1 574 339 Packaging and Paper 412 856 1 272 1 746 387 Tissue 124 269 413 602 119 Of which service 406 880 1 333 1 900 433 Process Performance Solutions 309 659 1 013 1 437 339 Flow Control 188 389 585 791 192 Automation Solutions 121 271 429 646 147 Total 1 212 2 536 3 831 5 359 1 184 Comparable EBITA, EUR million Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services 80 175 276 403 82 Process Performance Solutions 51 109 174 255 55 Other -11 -23 -32 -49 -16 Total 121 262 417 609 121 Comparable EBITA, % of net sales Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services 8.9 % 9.3 % 9.8 % 10.3 % 9.7 % Process Performance Solutions 16.5 % 16.5 % 17.1 % 17.7 % 16.2 % Total 10.0 % 10.3 % 10.9 % 11.4 % 10.2 % EBITA, EUR million Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services 77 165 248 364 80 Process Performance Solutions 50 107 172 248 54 Other -14 -27 -36 -56 -21 Total 114 245 384 557 113 EBITA, % of net sales Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services 8.6 % 8.8 % 8.8 % 9.3 % 9.5 % Process Performance Solutions 16.2 % 16.3 % 17.0 % 17.2 % 16.0 % Total 9.4 % 9.7 % 10.0 % 10.4 % 9.6 % Items affecting comparability, EUR million Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services -3 -11 -28 -39 -2 Process Performance Solutions -1 -1 -2 -7 -1 Other -3 -4 -4 -7 -5 Total -7 -16 -33 -53 -8 Amortization, EUR million Q1/2024 Q1-Q2/2024 Q1-Q3/2024 2024 Q1/2025 Biomaterial Solutions and Services -11 -21 -32 -36 -6 Process Performance Solutions -12 -26 -40 -54 -14 Other -4 -9 -13 -18 -5 Total -27 -56 -85 -108 -24 Further information, please contact: Pekka Rouhiainen, VP, Investor Relations, Valmet, tel. +358 10 672 0020 VALMETKatri HokkanenCFOPekka RouhiainenVP, Investor Relations DISTRIBUTION: Nasdaq HelsinkiMajor Valmet has a global customer base across various process industries. We are a leading global developer and supplier of process technologies, automation, and services for the pulp, paper, and energy industries. With our automation and flow control solutions, we serve an even wider base of process industries. Our more than 19,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward – every day. The company has more than 225 years of industrial history and a strong track record in continuous improvement, sustainability, and renewal. Valmet's net sales in 2024 were approximately EUR 5.4 billion. Valmet's shares are listed on the Nasdaq Helsinki, and the head office is in Espoo, Finland. Follow us on | X | X (IR) | LinkedIn | Facebook | YouTube | Instagram | Processing of personal data This information was brought to you by Cision View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 days ago
- Yahoo
Multiview Financial Software receives HFMA Peer Review designation
CHICAGO, June 04, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed Multiview's ERP solution using the Peer Review process. After undergoing the rigorous review, Multiview ERP has been awarded the Peer Reviewed by HFMA® designation. Multiview ERP delivers a single source of financial truth for healthcare organizations, giving finance teams the visibility they need across departments, facilities and service lines. More than just an accounting system, in addition to core accounting, general ledger, accounts payable and receivable, Multiview provides integrated tools for budgeting, reporting, materials management, and integrations with leading EMR and payroll solutions, so clients can focus on financial stewardship, not spreadsheets. Trusted by 400+ healthcare organizations across North America, Multiview supports financial leaders with the insights and control they need to manage complexity and plan for the future with confidence. 'Earning the HFMA Peer Reviewed designation is a significant milestone for us,' said Multiview President & CEO Mike Johnson. 'This recognition validates our unwavering commitment to delivering an ERP solution that meets the highest standards of effectiveness, quality and value, and also resonates with the real-world experiences of our healthcare clients. Knowing that our clients have played a key role in this assessment makes the achievement even more meaningful.' HFMA's Peer Review process provides healthcare financial managers with an objective, third-party evaluation of business solutions used in the healthcare workplace. The rigorous, 11-step process includes a Peer Review panel review composed of current customers, prospects who have not made a purchase, and industry experts. The Peer Review status of the healthcare business solution and its performance claims are based on effectiveness, quality and usability, price, value, and customer and technical support. "We are pleased to have Multiview achieve the HFMA Peer Reviewed designation," said HFMA Senior Vice President Professional Practice Richard L. Gundling, FHFMA, CMA. "The review process is built around an objective, third-party assessment of overall effectiveness, quality and value." About HFMA The Healthcare Financial Management Association (HFMA) equips its more than 135,000 members nationwide to navigate a complex healthcare landscape. Finance professionals in the full range of work settings, including hospitals, health systems, physician practices and health plans, trust HFMA to provide the guidance and tools to help them lead their organizations, and the industry, forward. HFMA is a not-for-profit, nonpartisan organization that advances healthcare by collaborating with other key stakeholders to address industry challenges and providing guidance, education, practical tools and solutions, and thought leadership. We lead the financial management of healthcare. About Multiview Financial Software Multiview Financial Software provides powerful, scalable ERP solutions that help hundreds of finance teams simplify operations and improve decision-making. With a proven and growing footprint and rated the number one ERP for healthcare organizations with under 300 beds by KLAS Research, and Peer Reviewed by HFMA, Multiview empowers healthcare finance teams with comprehensive tools for financial and materials management, reporting and analytics. Press inquiries should be directed to: Brad Dennison Healthcare Financial Management Association (708) 492-3385bdennison@ Connie Costigan Multiview Financial in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
